LALPATHLABUpdated 29 Aug 2026, 2:31

Dr. Lal Path Labs Ltd.

LALPATHLABUpdated 29 Aug 2026, 2:31

Market Cap

₹32,377Cr.

Current Price

₹1,931

High / Low

₹1,989/1,272

Stock P/E

57.2

ROE22.9%

ROCE28.5%

Book Value₹148

Face Value₹10.0

Dividend Yield0.72%

About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	17	17	17	14	17	14	16	13	13	15	16	18
Inventory Days	37	31	33	44	40	70	38	32	22	28	26	29
Days Payable	89	88	97	104	110	143	132	101	131	154	130	126
Cash Conversion Cycle	-35	-41	-47	-45	-54	-59	-79	-55	-96	-111	-88	-79
Working Capital Days	-10	28	15	18	1	-16	-25	-57	-61	-46	-28	-25
ROCE %	51%	48%	44%	38%	34%	33%	35%	32%	22%	26%	30%	29%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:31

DR. LAL PATH LABS LTD. (LALPATHLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding